SCHEMBL5508352

SCHEMBL5508352

N#CC(C#N)=C1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.60
HSD17B10 Q99714 1/20 0.60
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
EGFR P00533 1/20 0.31
GPR35 Q9HC97 1/20 0.31
HRH3 Q9Y5N1 1/20 0.30
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
RECQL P46063 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13349939 0.97 ALDH1A1 (0.64) ALDH1A1HSD17B10DRD2DRD3SMN1; SMN2
SCHEMBL19973070 0.97 ALDH1A1 (0.64) ALDH1A1HSD17B10DRD2DRD3SMN1; SMN2
SCHEMBL3708976 0.97 ALDH1A1 (0.64) ALDH1A1HSD17B10DRD2DRD3SMN1; SMN2
SCHEMBL2786474 0.87 ALDH1A1 (0.46) ALDH1A1HSD17B10DRD2DRD3EGFR
SCHEMBL7524147 0.82 ALDH1A1 (0.55) ALDH1A1HSD17B10DRD2DRD3SMN1; SMN2
Hydrochloric Acid SCHEMBL11032285 0.81 ALDH1A1 (0.43) ALDH1A1HSD17B10DRD2DRD3EGFR
SCHEMBL20990708 0.80 ALDH1A1 (0.44) ALDH1A1HSD17B10DRD2DRD3LMNA
SCHEMBL11199406 0.75 ALDH1A1 (0.43) ALDH1A1HSD17B10EGFRHRH3
SCHEMBL22826529 0.75 ALDH1A1 (0.39) ALDH1A1HSD17B10DRD2DRD3EGFR
SCHEMBL19973072 0.75 ALDH1A1 (0.39) ALDH1A1HSD17B10DRD2DRD3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116635373-B Amide derivatives and use thereof 康百达(四川)生物医药科技有限公司 2026-05-19 CN disclosed
US-20240376041-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2024-11-14 US disclosed
US-12098115-B2 Methods and compositions for terpenoid synthesis UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2024-09-24 US disclosed
US-11952327-B2 Methods and compositions for terpenoid synthesis UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2024-04-09 US disclosed
US-20240025843-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2024-01-25 US disclosed
US-20240025843-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2024-01-25 US disclosed
US-20230365509-A1 BENZO[H]QUINAZOLIN-4-AMINE AND THIENO[3,2-H]QUINAZOLIN-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER Redona Therapeutics, Inc. 2023-11-16 US disclosed
CN-116635373-A Amide derivatives and use thereof 成都百裕制药股份有限公司 2023-08-22 CN disclosed
WO-2022237782-A1 AMIDE DERIVATIVE AND APPLICATION THEREOF 成都百裕制药股份有限公司 2022-11-17 WO disclosed
EP-3414252-B1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS VALO HEALTH INC (US) 2022-07-06 EP disclosed
EP-1579266-A2 THIN PLANAR SWITCHES AND THEIR APPLICATIONS Citala Ltd. (IL) 2005-09-28 EP disclosed
US-20040131969-A1 Non-resonant two-photon absorbing material, non-resonant two-photon emitting material, method for inducing absorption of non-resonant two-photons and method for generating emission of non-resonant two-photons FUJI PHOTO FILM CO., LTD. 2004-07-08 US disclosed
WO-2002103436-A2 THIN PLANAR SWITCHES AND THEIR APPLICATIONS CITALA LTD. (IL) 2002-12-27 WO disclosed
US-5315014-A Fused heteroaromatic monomers for preparing low bandgap polymers BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1994-05-24 US disclosed
US-5274058-A Low bandgap polymers rf fused bithiophenes BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-12-28 US disclosed
WO-1993005077-A2 SUBSTITUTED CYCLOPENTADITHIOPHENE AND LOW BANDGAP POLYMERS THEREFROM BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-03-18 WO disclosed
US-4719245-A TRIMERIZATION CATALYST THE DOW CHEMICAL COMPANY (US) 1988-01-12 US disclosed
US-4703099-A CATALYTICALLY TRIMERIZING ISOCYANATES THE DOW CHEMICAL COMPANY (US) 1987-10-27 US disclosed
US-4632989-A KETENE AMINAL-OLEFIN REACTION PRODUCT AS CATALYSTS THE DOW CHEMICAL COMPANY (US) 1986-12-30 US disclosed
US-4536490-A REACTION PRODUCT OF KETENE-AMINAL AND UNSATURATED COMPOUND THE UPJOHN COMPANY (US) 1985-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365509-A1 BENZO[H]QUINAZOLIN-4-AMINE AND THIENO[3,2-H]QUINAZOLIN-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER H1-10, H1-3, H1-0 ALDH1A1 86/4885HSD17B10 1074/4885DRD2 1396/4885
US-11952327-B2 Methods and compositions for terpenoid synthesis SQLE, GGPS1, LSS ALDH1A1 1162/4885HSD17B10 686/4885DRD2 1203/4885
US-20240376041-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS SQLE, GGPS1, LSS ALDH1A1 1162/4885HSD17B10 686/4885DRD2 1203/4885
US-20240025843-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS SQLE, GGPS1, LSS ALDH1A1 1162/4885HSD17B10 686/4885DRD2 1203/4885
US-12098115-B2 Methods and compositions for terpenoid synthesis SQLE, GGPS1, LSS ALDH1A1 1162/4885HSD17B10 686/4885DRD2 1203/4885
US-20040131969-A1 Non-resonant two-photon absorbing material, non-resonant two-photon emitting material, method for inducing absorption of non-resonant two-photons and method for generating emission of non-resonant two-photons CRY2, BMP2, BMPR2 ALDH1A1 4571/4885HSD17B10 4714/4885DRD2 1776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.